SODIUM BENZOATE; SODIUM PHENYLACETATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for sodium benzoate; sodium phenylacetate and what is the scope of patent protection?
Sodium benzoate; sodium phenylacetate
is the generic ingredient in three branded drugs marketed by Bausch, Ailex Pharms Llc, Maia Pharms Inc, Navinta Llc, and B Braun, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.Eight suppliers are listed for this compound.
Summary for SODIUM BENZOATE; SODIUM PHENYLACETATE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 4 |
Patent Applications: | 2 |
DailyMed Link: | SODIUM BENZOATE; SODIUM PHENYLACETATE at DailyMed |
Recent Clinical Trials for SODIUM BENZOATE; SODIUM PHENYLACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Takeda | Phase 1 |
Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 2 |
Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 1 |
See all SODIUM BENZOATE; SODIUM PHENYLACETATE clinical trials
Pharmacology for SODIUM BENZOATE; SODIUM PHENYLACETATE
Drug Class | Nitrogen Binding Agent |
Mechanism of Action | Ammonium Ion Binding Activity |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM BENZOATE; SODIUM PHENYLACETATE
US Patents and Regulatory Information for SODIUM BENZOATE; SODIUM PHENYLACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ailex Pharms Llc | SODIUM PHENYLACETATE AND SODIUM BENZOATE | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 207096-001 | Feb 24, 2016 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Navinta Llc | SODIUM PHENYLACETATE AND SODIUM BENZOATE | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 217526-001 | Jul 14, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SODIUM BENZOATE; SODIUM PHENYLACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.